Corleen M. Roche insider trades

Open-market stock purchases and sales by Corleen M. Roche, Chief Financial Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Apr 19, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +229%.

Recent trades

DateStockTradeValue
Aug 6, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Aug 6, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$132K
Aug 6, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 9, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: other filings, last Aug 6, 2026
  • CGON CG Oncology, Inc: 1 buy, last Apr 15, 2025
  • IMNM Immunome Inc: other filings, last Jun 8, 2023

Get free alerts when Corleen M. Roche files a new trade →